Trial Profile
Planned pivotal phase III trial with BioPhage-PA for chronic otitis due to pseudomonal infections
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 08 Nov 2012
Price :
$35
*
At a glance
- Drugs AP PA01 (Primary)
- Indications Otorhinolaryngological infections; Pseudomonal infections
- Focus Registrational; Therapeutic Use
- 08 Nov 2012 New trial record